Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare Ozanimod (Zeposia) and UPADACITINIB (Rinvoq) — clinical data, side effects, and patient experiences.
Zeposia · S1P Receptor Modulator
How it works
S1P receptor 1,5 modulator that reduces circulating lymphocytes by retaining them in lymph nodes.
Approved for
Rinvoq · JAK Inhibitor
How it works
12.1 Mechanism of Action Upadacitinib is a Janus kinase (JAK) inhibitor. JAKs are intracellular enzymes which transmit signals arising from cytokine or growth factor-receptor inter...
Approved for
Estimated frequency (%) based on clinical trial data
No specific warnings
Based on 15 Reddit discussions
Ozanimod
0%
positive
0 threads
UPADACITINIB
60%
positive
15 threads
% of discussions mentioning each side effect
No community discussions found for Ozanimod yet.
15 Reddit threads analysed for UPADACITINIB
Overall Sentiment
Slightly positive
Comparison Threads
0
Avg Post Score
29 upvotes
Most discussed side effects in community
For context: for pretty much all of last year over 80% of my body was covered in eczema rash. It was so severe I couldn't use the shower and had to either take baths or wash myself in the sink. My scalp was constantly peeling and I was *always* itchy. While my skin would get better in summer, it was
#Earnings Advance Auto Parts (AAP) Q4 Adj. EPS USD 1.17 vs. Exp. USD 1.13, revenue USD 2.1bln vs. Exp. USD 2.11bln, SSS increased by 3.4%. Sees FY19 revenue USD 9.65bln-9.8bln vs. Exp. USD 9.78bln. (Newswires) Continental Resources (CLR) Q4 Adj. EPS USD 0.54 vs. Exp. USD 0.62, revenue USD 1.15
Hey everyone! I just wanted to provide some sort of update having been on Upadacitinib for just over a month. My eczema is gone and I no longer need to take cold showers and I don't even need to moisturise after showers. My skin looks healthy and clear it is so surreal. This medication is not a ste
Welcome back to this week's newsflash 1. Vedolizumab, a medication used for ulcerative colitis, shows promise in treating chronic pouchitis as well. A new study found it to be effective in reducing ulcer count and inducing mucosal healing. Do you want to know [more](https://www.healio.com/news/gastr
I am interested in participating in a clinical trial. I am leaning towards the 3 mentioned in the title, though I would love to hear about any others that seem promising. I am hoping there will be phase 3 trials in my area some time in the first half of 2018 for ABT-494 and PF-04965842. Phase 3 for
About 80% of my body was covered when I went to the dermatologist, so he sent me to hospital for inpatient treatment for 5 days. I did a paraffin bath -> topical steroid -> wet wrap -> emollient treatment twice a day and everything has cleared up. I've been given a metric tonne of moisturiz
Almost a year ago, after years of worsening Atopic Dermatitis, i said enough is enough, and decided to buy Upadacitinib, a JAK inhibitor originally used for rheumatoid arthritis, after reading about very promising clinical trials for AD. When i posted about it many of you guys were surprised about
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
Ozanimod is a S1P Receptor Modulator, while UPADACITINIB belongs to the JAK Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.
UPADACITINIB carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.